@article{TLCR20041,
author = {Jyoti Malhotra and Salma K. Jabbour},
title = {Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancer},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {Lung cancer is the leading cause of cancer mortality worldwide and non-small cell lung cancer (NSCLC) accounts for more than 85% of all lung cancers (1,2). The prognosis for patients with metastatic or stage IV NSCLC is extremely poor with five-year survival rates of less than 5% (3).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/20041}
}